header.gif

The page is dedicated to the latest published peer reviewed journals concerning Alzheimer's research, caregiver support and Advocacy.

updated March 12, 2007


Regulation of Alzheimer's disease amyloid-beta formation by casein kinase I
Marc Flajolet, Gen He, Myriam Heiman, Angie Lin, Angus C. Nairn, and Paul Greengard
PNAS 104: 4159-4164
[Abstract]

Spatial navigation deficit in amnestic mild cognitive impairment
Jakub Hort, Jan Laczó, Martin Vyhnálek, Martin Bojar, Jan Bures, and Kamil Vlcek
PNAS 104: 4042-4047
[Abstract]

Antihypertensive Medication Use and Incident Alzheimer Disease
Ara S. Khachaturian, PhD; Peter P. Zandi, PhD; Constantine G. Lyketsos, MD, MHS; Kathleen M. Hayden, PhD; Ingmar Skoog, MD, PhD; Maria C. Norton, PhD; JoAnn T. Tschanz, PhD; Lawrence S. Mayer, MD; Kathleen A. Welsh-Bohmer, PhD; John C. S. Breitner, MD; for the Cache County Study Group
Arch Neurol. 2006;63
[Abstract]

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study
Oskar Hansson, Henrik Zetterberg, Peder Buchhave, Elisabet Londos, Kaj Blennow and Lennart Minthon
Lancet Neurology, Volume 5, Issue 3, Pages 228-234
[Abstract]

Apolipoprotein E and alpha brain rhythms in mild cognitive impairment: A multicentric Electroencephalogram study (p 323-334)
Claudio Babiloni, Luisa Benussi, Giuliano Binetti, Emanuele Cassetta, Gloria Dal Forno, Claudio Del Percio, Florinda Ferreri, Raffaele Ferri, Giovanni Frisoni, Roberta Ghidoni, Carlo Miniussi, Guido Rodriguez, Gian Luca Romani, Rosanna Squitti, Maria Carla Ventriglia, Paolo M. Rossini
Annals of Neurology, Volume 59, Issue 2
[Abstract] 

Voluntary Exercise Decreases Amyloid Load in a Transgenic Model of Alzheimer's Disease
Paul A. Adlard, Victoria M. Perreau, Viorela Pop, and Carl W. Cotman

J. Neurosci. 2005 25: 4217-4221; doi:10.1523/JNEUROSCI.0496-05.2005  [Abstract]  [Full Text] 

A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease
Mark H Tuszynski1, Leon Thal1, Mary Pay, David P Salmon, Hoi Sang U, Roy Bakay, Piyush Patel, Armin Blesch, H Lee Vahlsing, Gilbert Ho, Gang Tong, Steven G Potkin, James Fallon, Lawrence Hansen, Elliott J Mufson, Jeffrey H Kordower, Christine Gall & James Conner.

read the article in the Nature: Medicine

Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment
Petersen R. C., Thomas R. G., Grundman M., Bennett D., Doody R., Ferris S., Galasko D., Jin S., Kaye J., Levey A., Pfeiffer E., Sano M., van Dyck C. H., Thal L. J., the Alzheimer's Disease Cooperative Study Group
 
N Engl J Med 2005; published at www.nejm.org on Apr 13, 2005 (10.1056/NEJMoa050151). Original Articles

Editorial to the above article


Mild Cognitive Impairment -- No Benefit from Vitamin E, Little from Donepezil
Blacker D.
 
N Engl J Med 2005; published at www.nejm.org on Apr 13, 2005 (10.1056/NEJMe058086). Editorials

 

Mild Cognitive Impairment Can Be Distinguished From Alzheimer Disease and Normal Aging for Clinical Trials
Michael Grundman; Ronald C. Petersen; Steven H. Ferris; Ronald G. Thomas; Paul S. Aisen; David A. Bennett; Norman L. Foster; Clifford R. Jack Jr; Douglas R. Galasko; Rachelle Doody; Jeffrey Kaye; Mary Sano; Richard Mohs; Serge Gauthier; Hyun T. Kim; Shelia Jin; Arlan N. Schultz; Kimberly Schafer; Ruth Mulnard; Christopher H. van Dyck; Jacobo Mintzer; Edward Y. Zamrini; Deborah Cahn-Weiner; Leon J. Thal
Arch Neurol. 2004;61:59-66. abstract only


Reduced Risk of Alzheimer Disease in Users of Antioxidant Vitamin Supplements.
Peter P. Zandi; James C. Anthony; Ara S. Khachaturian; Stephanie V. Stone; Deborah Gustafson; JoAnn T. Tschanz; Maria C. Norton; Kathleen A. Welsh-Bohmer; John C. S. Breitner
Archivies of Neurology 2004;61:82-88. abstract only
no PDF available

updated December 18, 2003
Role of the prolyl isomerase Pin1 in protecting against age-dependent neurodegeneration.
Liou YC, Sun A, Ryo A, Zhou XZ, Yu ZX, Huang HK, Uchida T, Bronson R, Bing G, Li X, Hunter T, Lu KP.
Nature. 2003 Jul 31;424(6948):556-61.
PDF

August 18, 2003
Alzheimer Disease in the US Population: Prevalence Estimates Using the 2000 Census
Liesi E. Hebert; Paul A. Scherr; Julia L. Bienias; David A. Bennett; Denis A. Evans
Archives of NeurologyVol. 60 No. 8, pp. 1119-1122, August 2003
PDF


June 19, 2003
Use It or Lose It—Do Effortful Mental Activities Protect Against Dementia
J.T Coyle
New England Journal of Medicine
Volume 348 June 19, 2003 Number 25  

May 22, 2003
Antibodies against beta-Amyloid Slow Cognitive Decline in Alzheimer's Disease
Christoph Hock *, Uwe Konietzko , Johannes R. Streffer , Jay Tracy , Andri Signorell , Britta MŸller-Tillmanns , Ulrike Lemke , Katharina Henke , Eva Moritz , Esmeralda Garcia , M. Axel Wollmer , Daniel Umbricht , Dominique J.F. de Quervain , Marc Hofmann , Alessia Maddalena , Andreas Papassotiropoulos , and Roger M. Nitsch *
Neuron, Vol 38, 547-554, 22 May 2003

April 3, 2003
Memantine in Moderate-to-Severe Alzheimer's Disease
Barry Reisberg, M.D., Rachelle Doody, M.D., Ph.D., Albrecht Stöffler, M.D., Frederick Schmitt, Ph.D., Steven Ferris, Ph.D., Hans Jörg Möbius, M.D., Ph.D., for the Memantine Study Group.
New England Journal of Medicine.
Volume 348:1333-1341 April 3, 2003 Number 14


Alzheimer’s Disease and Parkinson’s Disease
Robert L. Nussbaum, M.D., and Christopher E. Ellis, Ph.D.
download pdf


Clinic sites include Sacramento and Martinez. These clinics have been serving communities in Northern California since 1985. Satellite clinics in Oakland and Stockton improve services to minority and underserved residents.

Locations

Home   UC Davis   UCDMC   Neurology   IWEB